Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...

RHHBY has strengthened its pipeline with an agreement to acquire Regor's portfolio of next-generation CDK inhibitors for the treatment of breast cancer.

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...

Genentech to buy Regor's portfolio of next-generation CDK inhibitors to treat breast cancer: Cambridge, Massachusetts Tuesday, October 1, 2024, 10:00 Hrs [IST] Regor Pharmaceutica ...

As has been widely acknowledged, one of the most meaningful steps a business can take is to establish a single point of ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

A Feature on M&A, licensing and partnerships hotting up in inflammatory diseases as new targets present new opportunities for ...

Israeli troops crossed the border for the first time since 2006 in a ground operation targeting Hezbollah. The Israeli military called for evacuations in southern Lebanon. As a Crisis Builds ...

ASHEVILLE, North Carolina — Widespread devastation left behind by Hurricane Helene came into light Monday across the South, revealing a wasteland of splintered houses, crushed cargo containers ...

'Trust has become biggest casualty': What Army chief said on LAC standoff with China Army Chief Upendra Dwivedi stated that the situation along the LAC in eastern Ladakh is stable but sensitive ...

A trader works on the trading floor at The New York Stock Exchange (NYSE), in New York City, U.S., September 18, 2024. REUTERS/Andrew Kelly/File Photo The S&P 500 sputtered to a record high close ...